Detalhe da pesquisa
1.
Factor XI deficiency: phenotypic age-related considerations and clinical approach towards bleeding risk assessment.
Blood
; 143(15): 1455-1464, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194679
2.
Emicizumab prophylaxis in infants: Single-centre experience.
Br J Haematol
; 204(4): 1375-1382, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38266507
3.
Bleeding phenotype and hemostatic evaluation by thrombin generation in children with Noonan syndrome: A prospective study.
Pediatr Blood Cancer
; 71(2): e30761, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37974388
4.
Association between Thrombin Generation and Clinical Characteristics in COVID-19 Patients.
Acta Haematol
; 146(2): 151-160, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36273451
5.
3K3A-Activated Protein C Inhibits Choroidal Neovascularization Growth and Leakage and Reduces NLRP3 Inflammasome, IL-1ß, and Inflammatory Cell Accumulation in the Retina.
Int J Mol Sci
; 24(13)2023 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37445820
6.
Anti-TFPI for hemostasis induction in patients with rare bleeding disorders, an ex vivo thrombin generation (TG) guided pilot study.
Blood Cells Mol Dis
; 95: 102663, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35525014
7.
3K3A-Activated Protein C Prevents Microglia Activation, Inhibits NLRP3 Inflammasome and Limits Ocular Inflammation.
Int J Mol Sci
; 23(22)2022 Nov 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36430674
8.
The potential role of emicizumab prophylaxis in severe von Willebrand disease.
Blood Cells Mol Dis
; 87: 102530, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33341070
9.
Emicizumab prophylaxis in haemophilia patients older than 50 years with cardiovascular risk factors: Real-world data.
Haemophilia
; 27(2): 253-260, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33595174
10.
Emicizumab prophylaxis: Prospective longitudinal real-world follow-up and monitoring.
Haemophilia
; 27(3): 383-391, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33892524
11.
Molecular Mechanisms of Skewed X-Chromosome Inactivation in Female Hemophilia Patients-Lessons from Wide Genome Analyses.
Int J Mol Sci
; 22(16)2021 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445777
12.
Emicizumab treatment and monitoring in a paediatric cohort: real-world data.
Br J Haematol
; 191(2): 282-290, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32656767
13.
Thrombin generation in plasma of patients with haemophilia A and B with inhibitors: Effects of bypassing agents and antithrombin reduction.
Blood Cells Mol Dis
; 82: 102416, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066048
14.
Allergy and inhibitors in hemophilia - a rare complication with potential novel solutions.
Blood Cells Mol Dis
; 80: 102370, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31669933
15.
Activated protein C induces suppression and regression of choroidal neovascularization- A murine model.
Exp Eye Res
; 186: 107695, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31201804
16.
Emicizumab prophylaxis among infants and toddlers with severe hemophilia A and inhibitors-a single-center cohort.
Pediatr Blood Cancer
; 66(11): e27886, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31348595
17.
Comparison of Subconjunctival Aflibercept and Betamethasone for the Treatment of Formed Corneal Neovascularization in a Rabbit Model.
Ophthalmic Res
; 62(2): 116-122, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112967
18.
The Histone Deacetylase Inhibitor AN7, Attenuates Choroidal Neovascularization in a Mouse Model.
Int J Mol Sci
; 20(3)2019 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30736437
19.
A novel approach using ancillary tests to guide treatment of Glanzmann thrombasthenia patients undergoing surgical procedures.
Blood Cells Mol Dis
; 72: 44-48, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30078718
20.
Treatment tailoring for factor V deficient patients and perioperative management using global hemostatic coagulation assays.
Blood Cells Mol Dis
; 71: 5-10, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29402705